What is the case pharma giant is fighting in US over glyphosate-based herbicides?

In August, a jury in California said that Monsanto (the company which Bayer acquired in 2018), should have warned of the alleged cancer risks. Bayer, however, has said it has strong support from US farmers who want the company to keep the product.

Monsanto, Monsanto fined, glyphosate-based herbicides, Monsanto sued, Monsanto case, Roundup cancer trial, Monsanto cancer

A man uses a Monsanto’s Roundup weedkiller spray containing glyphosate in a garden (REUTERS/Regis Duvignau/File Photo)

German pharma company Bayer is facing thousands of lawsuits over one of its products. A Reuters report said 42,700 plaintiffs in the US are blaming Bayer’s herbicides for their cancer, up from 18,400 plaintiffs in July this year. In August, a jury in California said that Monsanto (the company which Bayer acquired in 2018), should have warned of the alleged cancer risks. Reuters quoted Bayer as claiming, however, that it has strong support from US farmers who want the company to keep the product.